KRON

1.00

1.96% -0.02

Handel nachbörslich: .96 -0.04 -4.00%

Kronos Bio Inc (KRON)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$1.02

Offen:

$1.03

24-Stunden-Volumen:

392.16K

Relative Volume:

1.22

Marktkapitalisierung:

$60.34M

Einnahmen:

Nettoeinkommen (Verlust:

$-112.67M

KGV:

-0.5128

EPS:

-1.95

Netto-Cashflow:

$-79.26M

1W Leistung:

-1.96%

1M Leistung:

+0.99%

6M Leistung:

-0.99%

1J Leistung:

-4.76%

1-Tages-Spanne:

$0.982

$1.03

1-Wochen-Bereich:

$0.9696

$1.04

52-Wochen-Spanne:

$0.69

$1.60

Kronos Bio Inc Stock (KRON) Company Profile

Firmenname

Kronos Bio Inc

Sektor

Healthcare (1169)

Branche

Biotechnology (678)

Telefon

(650) 781-5200

Adresse

1300 S. EL CAMINO REAL, SAN MATEO

Mitarbeiter

Twitter

Nächster Verdiensttermin

2024-11-11

Neueste SEC-Einreichungen

KRON's Discussions on Twitter

Vergleichen Sie KRON mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
KRON Kronos Bio Inc	1.00	60.34M	0	-112.67M	-79.26M	-1.95
VRTX Vertex Pharmaceuticals Inc	484.24	124.35B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	700.33	76.56B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	644.48	39.16B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	250.59	32.44B	2.25B	-278.16M	-42.59M	-2.17
BNTX Biontech Se Adr	120.01	28.77B	3.30B	-501.07M	1.03B	-2.1146

Kronos Bio Inc Stock (KRON) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-11-14	Herabstufung	Piper Sandler	Overweight → Neutral
2024-11-14	Herabstufung	TD Cowen	Buy → Hold
2022-09-14	Eingeleitet	Berenberg	Buy
2021-10-20	Fortgesetzt	Cowen	Outperform
2021-06-24	Eingeleitet	H.C. Wainwright	Buy
2020-11-03	Eingeleitet	Cowen	Outperform
2020-11-03	Eingeleitet	Goldman	Buy
2020-11-03	Eingeleitet	Jefferies	Buy
2020-11-03	Eingeleitet	Piper Sandler	Overweight

Alle ansehen

Kronos Bio Inc Aktie (KRON) Neueste Nachrichten

Feb 17, 2025

Layoff Tracker: Kojin Will Soon Close Its Doors, Affecting 25 Employees - BioSpace

Feb 17, 2025

Kronos Bio, Inc. (NASDAQ:KRON) Shares Sold by Partners Capital Investment Group LLP - MarketBeat

Feb 17, 2025

Feb 16, 2025

Peapod Lane Capital LLC Purchases New Position in Kronos Bio, Inc. (NASDAQ:KRON) - MarketBeat

Feb 16, 2025

Jan 20, 2025

Kronos Bio Stock Jumps After Deep Workforce Cuts And CEO Shuffle: Retail Aligns With Shake-Up - MSN

Jan 20, 2025

Jan 19, 2025

Short Interest in Kronos Bio, Inc. (NASDAQ:KRON) Increases By 16.5% - MarketBeat

Jan 19, 2025

Jan 13, 2025

We Think Kronos Bio (NASDAQ:KRON) Needs To Drive Business Growth Carefully - Yahoo Finance

Jan 13, 2025

Jan 11, 2025

Analyzing Kronos Bio (NASDAQ:KRON) and Aerovate Therapeutics (NASDAQ:AVTE) - Defense World

Jan 11, 2025

Jan 02, 2025

Fierce Biotech Layoff Tracker 2024: Vincerx reduces workforce; Novartis lays off 330 staffers - Fierce Biotech

Jan 02, 2025

Jan 01, 2025

Kronos Bio (NASDAQ:KRON) Stock Price Down 1.8% – Here’s What Happened - Defense World

Jan 01, 2025

Kronos Bio (NASDAQ:KRON) Stock Price Down 1.8%Should You Sell? - MarketBeat

Jan 01, 2025

Dec 28, 2024

Kronos Bio ends partnership with Genentech By Investing.com - Investing.com Australia

Dec 28, 2024

Struggling Bay Area biotech firm Kronos, once worth $1B, lays off almost entire staff - SFGATE

Dec 03, 2024

Dec 02, 2024

Biotech with Cambridge lab slashes 83% of staff, CEO departs - NBC Boston

Dec 02, 2024

Dec 01, 2024